Nintedanib Inhibits Endothelial Mesenchymal Transition in Bleomycin-Induced Pulmonary Fibrosis via Focal Adhesion Kinase Activity Reduction.

MLA

Yu, Wen-Kuang, et al. “Nintedanib Inhibits Endothelial Mesenchymal Transition in Bleomycin-Induced Pulmonary Fibrosis via Focal Adhesion Kinase Activity Reduction.” International Journal of Molecular Sciences, vol. 23, no. 15, Aug. 2022, p. 8193. EBSCOhost, https://doi.org/10.3390/ijms23158193.

APA

Yu, W.-K., Chen, W.-C., Su, V. Y.-F., Shen, H.-C., Wu, H.-H., Chen, H., & Yang, K.-Y. (2022). Nintedanib Inhibits Endothelial Mesenchymal Transition in Bleomycin-Induced Pulmonary Fibrosis via Focal Adhesion Kinase Activity Reduction. International Journal of Molecular Sciences, 23(15), 8193. https://doi.org/10.3390/ijms23158193

Chicago

Yu, Wen-Kuang, Wei-Chih Chen, Vincent Yi-Fong Su, Hsiao-Chin Shen, Huai-Hsuan Wu, Hao Chen, and Kuang-Yao Yang. 2022. “Nintedanib Inhibits Endothelial Mesenchymal Transition in Bleomycin-Induced Pulmonary Fibrosis via Focal Adhesion Kinase Activity Reduction.” International Journal of Molecular Sciences 23 (15): 8193. doi:10.3390/ijms23158193.